Effective treatment of painful bone crises in type I Gaucher's disease with high dose prednisolone

Archives of Disease in Childhood

Volumn 75, Issue 3, 1996, Pages 218-222

  Cohen, Ian Joseph ^a   Kornreich, Liora ^a   Mekhmandarov, Sergey ^a   Katz, Kalman ^a   Zaizov, Rina ^a  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

Author keywords

Bone crises; Gaucher's disease; High dose prednisolone

Indexed keywords

PREDNISOLONE;

ADOLESCENT; ADULT; ANALGESIC ACTIVITY; ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DRUG EFFICACY; DRUG MEGADOSE; GAUCHER DISEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0029786937     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.75.3.218     Document Type: Article

References (26)

1. Zimran A. Phenotype correlation in Israeli patients with Gaucher's disease. Abstract Book, NIH Technology Assessment Conference on Gaucher's Disease. Current issues in diagnosis and treatment. February 27-March 1, 1995. Bethesda, Maryland, USA:39.
2. Yosipovitch Z, Herman G, Makin M. Aseptic osteomyelitis in Gaucher's disease. Isr J Med Sci 1965;1:531-6.
3. Yosipovitch Z, Katz K. Bone crises in Gaucher disease - an update. Isr J Med Sci 1990;26:593-5.
4. Katz K, Mechlis-Frish S, Cohen IJ, Horev G, Zaizov R, Lubin E. Bone scans in diagnosis of bone crises in patients who have Gaucher's disease. J Bone Joint Surg Am 1991;73A:513-7.
5. Cremin BJ, Davey H, Goldblatt J. Skeletal complications of type I Gaucher's disease: the magnetic resonance features. Clin Radiol 1990;41:244-7.
6. Horev G, Kornreich L, Hadar H, Katz K. Hemorrhage associated with 'bone crises' in Gaucher's disease identified by magnetic resonance imaging. Skel Radiol 1991;20:479-82.
7. Lanir A, Hadar H, Cohen I, Tal Y, Benmair J , Schrieber R, et al. Gaucher's disease: assessment with MRI. Radiology 1986;161:239-44.
8. Frenkel EP. Southwestern Internal Medicine Conference: Gaucher disease: a heterogeneous clinical complex for which effective enzyme replacement has come of age. Am J Med Sci 1993;305:331-4.
9. Singleton EB. Film panel. Cases of pediatric radiology. Pediatr Radiol 1990;20:373.
10. Greenfield GB. Bone changes in chronic adult Gaucher's disease. Am J Radiol 1970;110:800-7.
11. Katz K, Cohen IJ, Ziv N, Grunebaum M, Zaizov R, Yosipovitch Z. Fractures in children who have Gaucher's disease. J Bone Joint Surg Am 1987;69A:1361-9.
12. Ashkenazi A, Zaizov R, Matoth Y. Effect of splenectomy on destructive bone changes in children with chronic (type I) Gaucher's disease. Eur J Pediatr 1986;145:138-41.
13. Cohen IJ, Katz K, Freud E, Zer M, Zaizov R. Long-term follow-up of partial splenectomy in Gaucher's disease. Am J Surg 1992;164:345-7.
14. Mankin HJ, Doppett SH, Rosenberg AE, Barranger JA. Metabolic bone disease in patients with Gaucher's disease. In: Avoli LV, Krane SM, eds. Metabolic disease and clinically related disorders, 2nd Ed. Philadelphia: WB Saunders, 1990: 730-52.
15. Siegal JP, Puri RK. Interleukin-2 toxicity. J Clin Oncol 1991; 9:694-704.
16. Okusawa S, Gelfand JA, Ikejima T. Interleukin-1 induces a shock-like state in rabbits. J Clin Invest 1988;81:1162-72.
17. Mier JW , Vachino G, Van der Meer JW, Numerof RP, Adams S, Cannon JG, et al. Induction of circulating tumor necrosis factor (TNF alpha) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients. J Clin Immunol 1988;8:426-36.
18. Cotran RS, Pober JS. Effects of cytokines on vascular endothelium: their role in vascular and immune injury. Kidney Int 1989;35:969-75.
19. Gery IJ, Zigler S, Brady RO. Selective effects of glucocerebroside (Gaucher's storage material) on macrophage cultures. J Clin Ivest 1981;68:1182-9.
20. Remick DG, Stricter RM, Lynch JP, Eskandari M, Kunkel SL. In vivo dynamics of murine tumor necrosis factor-alpha gene expression. Lab Invest 1989;60:766-71.
21. Cohen IJ. Cardiovascular collapse after high-dose methyl-prednisolone. Pediatr Hematol Oncol 1993;10:V-VII.
22. Griffin TC, McIntire D, Buchanan GR. High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease. N Engl J Med 1994;330:733-7.
23. Noyes FR, Smith W. Bone crises and chronic osteomyelitis in Gaucher's disease. Clin Orthop 1971;79:132-40.
24. Pastores GM, Sibille AR, Grabowski GA. Enzyme therapy in Gaucher's disease type I: dosage efficacy and adverse effects in 33 patients treated for 6 to 24 months. Blood 1993;82:408-16.
25. Samuel R, Katz K, Papapoulous SE, Yosipovitch Z, Zaizov R, Liberman UA. Aminohydroxy propylidine bisphosphonate (APD) treatment improves the clinical skeletal manifestations of Gaucher's disease. Pediatrics 1994;94: 385-95.
26. Zaizov R, Frisch A, Cohen IJ. Low-dose high frequency enzyme replacement therapy in children with type I Gaucher's disease: experience at the Children's Medical Center of Israel. Semin Hematol 1995;32(suppl 1):39-44.